85 results
Page 3 of 5
6-K
lu5xdcqpy0wn9u 4c
16 Aug 21
Current report (foreign)
7:00am
6-K
k9k84bfv
11 May 21
Current report (foreign)
7:00am
POS AM
bhkf6usaw38qq7zfeyi
19 Apr 21
Prospectus update (post-effective amendment)
5:17pm
424B8
o4wcgbhp670zw
19 Apr 21
Prospectus unintentially filed late
5:06pm
6-K
EX-1.1
810dhltwjj7tnn9k6kn
12 Apr 21
Vascular Biogenics Ltd. Prices Public Offering of Ordinary Shares and Pre-Funded Warrants
9:10am
424B5
vg1h9 lq2sl
12 Apr 21
Prospectus supplement for primary offering
9:07am
424B5
tdjct26rrae3
9 Apr 21
Prospectus supplement for primary offering
12:00am
424B5
zotv1dq ig
15 Jan 21
Prospectus supplement for primary offering
7:00am
F-3
20s vu2adgwo
30 Dec 20
Shelf registration (foreign)
4:17pm
F-1
sjyujy0e9jl61bh
1 Jun 20
Registration statement (foreign)
12:18pm
6-K
EX-10.1
pmwtrszx
12 May 20
Current report (foreign)
12:04pm
424B5
1q5ot9m
12 May 20
Prospectus supplement for primary offering
12:02pm
6-K
EX-10.1
i0d1p7cx67f79v2 lxp
11 May 20
VBL Therapeutics Announces $10.0 Million Registered Direct Offering
9:23am
424B5
vvy5v u63ztzcb
11 May 20
Prospectus supplement for primary offering
9:23am